Glipizide

Clinical Guidance

Type 2 Diabetes

Pharmacologic Intervention

Sulfonylureas

Steven V. Edelman, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

News

July 23, 2024

2 min read

Save

Semaglutide does not raise risk for neurologic disorders for adults with type 2 diabetes

Semaglutide was not associated with increased risks for adverse neurologic or psychological disorders at 1 year compared with other diabetes drugs, according to data published in eClinicalMedicine.